The Latest Cardiac and Vascular News
The Birmingham Heart Clinic partnership represents USHV’s 1st in the state. BIRMINGHAM, Ala., Oct. 18, 2024 /PRNewswire/ — US Heart & Vascular (“USHV”), a national provider of support services to cardiovascular physician practices, has partnered with Birmingham Heart Clinic (“Birmingham…
MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT® Editorial Panel has accepted new Current Procedural Terminology (CPT) Category I codes for baroreflex activation therapy (“Barostim”) to treat the symptoms of heart failure.
New reimbursement code follows recent favorable Medicare coverage decision, expanding access to HeartFlow’s Plaque Analysis to help physicians provide personalized treatment plans New reimbursement code follows recent favorable Medicare coverage decision, expanding access to HeartFlow’s Plaque Analysis to help physicians provide personalized treatment plans
SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful insights wherever the patient is, announced that Robert Eno has been appointed Chief Executive Officer (CEO), effective Monday, October 21, 2024. The seasoned MedTech executive joined HeartBeam as President in January […]
SHERIDAN, Wyo., Oct. 17, 2024 /PRNewswire/ — Radin Health, a leading provider of AI-powered, cloud-based radiology workflow solutions, has announced the addition of Marc Shapiro as Chief Commercial Officer (CCO) to advance and shape a sustainable, long-term commercial sales strategy….
Partnership broadens HealthSnap’s RPM and CCM platform to offer the industry’s most comprehensive virtual care management platform for health systems MIAMI, Oct. 16, 2024 /PRNewswire/ — HealthSnap, a leading virtual care management company that currently partners with over 150 health…
NDA for Aficamten Submitted to FDA in Q3
Key points: Wearable AF monitoring devices are extensively used in routine practice worldwide. The FDA has agreed on the use of AF monitoring devices in clinical trials for budiodarone approval. The FDA has also issued guidance on the steps required to incorporate wearable AF monitoring…
BUDAPEST, Hungary, Oct. 15, 2024 /PRNewswire/ — CardioSight, Inc., developers of a revolutionary intra-cardiac visualization and interventional platform, announces the appointment of Steve Motes as Chief Executive Officer effective October 15, 2024. Steve brings to CardioSight more than…
BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
